As of 28 Aug 2026, Molbio Diagnostics Ltd share price is ₹1,145.40. The stock opened at ₹1,145.40 and had closed at ₹1,242.80 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹925.80 and a high of ₹1,261.00. In terms of performance, Molbio Diagnostics Ltd share price has increased by 4.13% over the past six months and has increased by 10.53% over the last year.
MOLBIO Charts
Molbio Diagnostics Ltd Overview
About MOLBIO
Molbio Diagnostics are an innovative point-of-care (“POC”) diagnostics company focused on expanding access to accurate, rapid and cost-effective healthcare technologies to diagnose infectious and non-communicable diseases.
Molbio Diagnostics Ltd Historical Performance
Molbio Diagnostics Ltd Fundamental Analysis
Molbio Diagnostics Ltd Financials
| Indicator | No Data Available |
|---|---|
| Revenue | |
| EBITDA | |
| Net Profit | |
| EPS |
Molbio Diagnostics Ltd Technical Analysis
| Indicator | Value |
|---|---|
| RSI | 77.85 |
| MACD | - |
| 20-Day SMA | - |
Molbio Diagnostics Ltd Corporate Actions
| Corporate Action | Ex Date | Record Date |
|---|---|---|
| No forthcoming board meetings available. | ||
Molbio Diagnostics Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Apollo Hospitals Enterprise LtdAPOLLOHOSP | ₹8,800.00+0.38% | ₹1,10,231.07 | 59.08 | 20.48% |
| Max Healthcare Institute LtdMAXHEALTH | ₹1,009.00+0.40% | ₹1,02,534.79 | 72.27 | 13.42% |
| Fortis Healthcare LtdFORTIS | ₹915.65+0.20% | ₹68,746.49 | 70.10 | 10.53% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Molbio Diagnostics Ltd today is ₹1,145.40 on NSE and ₹1,145.40 on BSE.
- The 52-week high of Molbio Diagnostics Ltd is ₹1,261.00, while the 52-week low is ₹925.80.
- The current market capitalisation of Molbio Diagnostics Ltd is approximately ₹13,200 crore.
- The P/E (Price-to-Earnings) ratio of Molbio Diagnostics Ltd is 0.00. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Molbio Diagnostics Ltd is 0.00. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To invest in Molbio Diagnostics Ltd shares,
• Open a Demat and trading account with a registered broker
• Add funds to your account
• Search for Molbio Diagnostics Ltd on the trading platform
• Place a buy order
• Track your investments - Over the past 3 years, Molbio Diagnostics Ltd has delivered a return of approximately N/A. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Molbio Diagnostics Ltd comprises different categories of shareholders. As of Aug 2026, the shareholding is approximately 41.29% promoters, -0.74% FIIs, 16.37% DIIs, and 27.64% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
